Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-13 Sale | 2023-09-25 8:36 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 1,682 | $50.34 | $84,672 | 460,998 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:31 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 632 | $50.34 | $31,815 | 18,468 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:31 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,617 | $48.32 | $271,416 | 71,182 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:30 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 531 | $50.34 | $26,731 | 150,689 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:28 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 562 | $50.34 | $28,291 | 243,177 (Indirect Direct) | View |
| 2023-09-01 Sale | 2023-09-18 6:48 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $49.77 | $1,244,248 | 527,680 (Direct) | View |
| 2023-08-28 Sale | 2023-08-30 7:04 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,745 | $49.99 | $287,191 | 76,799 (Direct) | View |
| 2023-08-08 Purchase | 2023-08-10 4:46 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 25,000 | $42.06 | $1,051,475 | 602,168 (Indirect Direct) | View |
| 2023-08-01 Sale | 2023-08-03 4:13 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $43.15 | $1,078,867 | 537,680 (Direct) | View |
| 2023-07-28 Purchase | 2023-08-01 7:52 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 55,000 | $42.95 | $2,362,234 | 577,168 (Indirect Direct) | View |
| 2023-07-03 Sale | 2023-07-06 8:44 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $44.88 | $1,122,041 | 562,680 (Direct) | View |
| 2023-06-21 Sale | 2023-06-23 8:06 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 33,349 | $51.74 | $1,725,390 | 46,627 (Direct) | View |
| 2023-06-20 Sale | 2023-06-22 5:20 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,777 | $55 | $1,142,735 | 243,429 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 5:54 pm | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $54.67 | $1,421,529 | 0 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 5:47 pm | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 40,000 | $54.17 | $2,166,685 | 14,797 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 5:46 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 78,200 | $54.78 | $4,284,066 | 154,016 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:41 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 606 | $55.16 | $33,427 | 22,377 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:38 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 1,613 | $55.16 | $88,973 | 407,680 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:35 pm | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 509 | $55.16 | $28,076 | 189,420 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:35 pm | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 538 | $55.16 | $29,676 | 243,739 (Indirect Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:29 pm | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 591 | $55.16 | $32,600 | 79,976 (Direct) | View |
| 2022-09-19 Purchase(A) | 2023-06-15 9:26 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) | View |
| 2023-06-01 Sale | 2023-06-05 6:23 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $45.1 | $1,127,430 | 613,831 (Direct) | View |
| 2023-05-19 Purchase | 2023-05-23 9:55 pm | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 520,000 | $29.69 | $15,440,000 | 522,168 (Indirect Direct) | View |
| 2023-05-01 Sale | 2023-05-03 8:28 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 25,000 | $45.07 | $1,126,860 | 652,373 (Direct) | View |
| 2023-04-03 Sale | 2023-04-05 4:55 pm | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 25,000 | $37.94 | $948,576 | 480,161 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-09-21 Exercise | 2023-09-25 8:31 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,000 | $0 | 71,182 (Direct) | View |
| 2023-09-21 Exercise | 2023-09-25 8:31 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,000 | $6.36 | 71,182 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-18 6:48 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $0 | 527,680 (Direct) | View |
| 2023-09-01 Exercise | 2023-09-18 6:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $6.36 | 527,680 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-30 7:04 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 15,000 | $0 | 564,892 (Direct) | View |
| 2023-08-30 Exercise | 2023-08-30 7:04 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 15,000 | $0.615 | 564,892 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-30 7:04 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,745 | $0 | 76,799 (Direct) | View |
| 2023-08-28 Exercise | 2023-08-30 7:04 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 5,745 | $6.36 | 76,799 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 4:13 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $0 | 537,680 (Direct) | View |
| 2023-08-01 Exercise | 2023-08-03 4:13 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $6.36 | 537,680 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 8:44 pm | N/A 2029-01-15 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $0 | 562,680 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-06 8:44 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $6.36 | 562,680 (Direct) | View |
| 2023-06-27 Exercise | 2023-06-27 7:12 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 40,000 | $0 | 564,892 (Direct) | View |
| 2023-06-27 Exercise | 2023-06-27 7:12 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 40,000 | $0.615 | 564,892 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 6:00 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Xu Yuan Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:58 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Judy Chou Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:55 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:52 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:48 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Graham G. Walmsley Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:48 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Harrison Seth Loring Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-27 5:39 pm | N/A 2033-06-22 | Akero Therapeutics Inc. | AKRO | Iwicki Mark T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 5:20 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 17,500 | $0 | 243,429 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 5:20 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 17,500 | $7.009 | 243,429 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:54 pm | N/A 2030-06-09 | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $0 | 0 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:54 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Heyman Tomas J. Director | 26,000 | $25.04 | 0 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:47 pm | N/A 2029-04-02 | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 40,000 | $0 | 14,797 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:47 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Henderson Jane Director | 40,000 | $7.01 | 14,797 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:46 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 40,000 | $0.61 | 154,016 (Direct) | View |
| 2023-06-16 Exercise | 2023-06-21 5:46 pm | N/A 2028-07-29 | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 40,000 | $0 | 154,016 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-05 6:23 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 25,000 | $0 | 613,831 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-05 6:23 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 3,670 | $6.36 | 613,831 (Direct) | View |
| 2023-06-01 Exercise | 2023-06-05 6:23 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO | 21,330 | $0.615 | 613,831 (Direct) | View |
| 2023-04-18 Exercise | 2023-05-03 8:28 pm | N/A 2028-09-07 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 65,000 | $0 | 652,373 (Direct) | View |
| 2023-04-18 Exercise | 2023-05-03 8:28 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 65,000 | $0.615 | 652,373 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:55 pm | N/A 2028-10-17 | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 25,000 | $0 | 480,161 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 4:55 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 25,000 | $0.615 | 480,161 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 4:25 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 641 | $43.47 | 22,983 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 4:20 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Yale Catriona Chief Development Officer | 701 | $43.46 | 80,567 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 4:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Young Jonathan Chief Operating Officer | 634 | $43.47 | 244,277 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 4:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Rolph Timothy Chief Scientific Officer | 603 | $43.47 | 189,929 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 4:18 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO | 1,706 | $43.47 | 369,293 (Direct) | View |